ATE406918T1 - Radiotherapeutische mittel enthaltend zin-117m - Google Patents

Radiotherapeutische mittel enthaltend zin-117m

Info

Publication number
ATE406918T1
ATE406918T1 AT95917088T AT95917088T ATE406918T1 AT E406918 T1 ATE406918 T1 AT E406918T1 AT 95917088 T AT95917088 T AT 95917088T AT 95917088 T AT95917088 T AT 95917088T AT E406918 T1 ATE406918 T1 AT E406918T1
Authority
AT
Austria
Prior art keywords
bone pain
palliation
provides
zin
cancer patients
Prior art date
Application number
AT95917088T
Other languages
English (en)
Inventor
Suresh Srivastava
George Meinken
Leonard Mausner
Harold Atkins
Original Assignee
Brookhaven Science Ass Llc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Brookhaven Science Ass Llc filed Critical Brookhaven Science Ass Llc
Application granted granted Critical
Publication of ATE406918T1 publication Critical patent/ATE406918T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
    • A61K51/04—Organic compounds
    • A61K51/0474—Organic compounds complexes or complex-forming compounds, i.e. wherein a radioactive metal (e.g. 111In3+) is complexed or chelated by, e.g. a N2S2, N3S, NS3, N4 chelating group
    • A61K51/0478—Organic compounds complexes or complex-forming compounds, i.e. wherein a radioactive metal (e.g. 111In3+) is complexed or chelated by, e.g. a N2S2, N3S, NS3, N4 chelating group complexes from non-cyclic ligands, e.g. EDTA, MAG3
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
    • A61K51/04—Organic compounds
    • A61K51/0489—Phosphates or phosphonates, e.g. bone-seeking phosphonates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2121/00—Preparations for use in therapy
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2123/00—Preparations for testing in vivo

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Physics & Mathematics (AREA)
  • Optics & Photonics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Engineering & Computer Science (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Biomedical Technology (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
AT95917088T 1994-05-02 1995-04-21 Radiotherapeutische mittel enthaltend zin-117m ATE406918T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US23700394A 1994-05-02 1994-05-02

Publications (1)

Publication Number Publication Date
ATE406918T1 true ATE406918T1 (de) 2008-09-15

Family

ID=22891937

Family Applications (1)

Application Number Title Priority Date Filing Date
AT95917088T ATE406918T1 (de) 1994-05-02 1995-04-21 Radiotherapeutische mittel enthaltend zin-117m

Country Status (15)

Country Link
US (2) US5853695A (de)
EP (1) EP0758252B1 (de)
JP (2) JP3122319B2 (de)
CN (1) CN1216644C (de)
AT (1) ATE406918T1 (de)
AU (1) AU708204B2 (de)
CA (1) CA2188133C (de)
DE (1) DE69535828D1 (de)
DK (1) DK0758252T3 (de)
ES (1) ES2314977T3 (de)
HU (1) HU221423B1 (de)
PT (1) PT758252E (de)
RU (1) RU2160121C2 (de)
WO (1) WO1995029706A1 (de)
ZA (1) ZA953393B (de)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6022521A (en) * 1995-05-04 2000-02-08 The Regents Of The University Of Michigan Method of establishing the optimal radiation dose for radiopharmaceutical treatment of disease
US6231832B1 (en) * 1998-03-23 2001-05-15 Brookhaven Science Associates Radiopharmaceutical stannic Sn-117m chelate compositions and methods of use
US6004532A (en) * 1998-06-08 1999-12-21 Brookhaven Science Associates Formulation for Tin-117m /diethylenetriaminepentaacetic acids
RU2260217C2 (ru) 1999-11-30 2005-09-10 Скотт ШЕНТЕР Способ получения актиния-225 и его дочерних элементов
US7138127B1 (en) 2000-01-19 2006-11-21 Allergan, Inc. Clostridial toxin derivatives and methods for treating pain
US6500436B2 (en) 2000-01-19 2002-12-31 Allergan, Inc. Clostridial toxin derivatives and methods for treating pain
US6641820B1 (en) * 2000-01-19 2003-11-04 Allergan, Inc. Clostridial toxin derivatives and methods to treat pain
US7112570B2 (en) * 2000-08-24 2006-09-26 Neuren Pharmaceuticals, Ltd. GPE analogs
US6541514B2 (en) 2001-05-02 2003-04-01 Brookhaven Science Associates, Llc Process for the manufacture of 117Sn diethylenetriaminepentaacetic acids
RU2270045C1 (ru) * 2004-06-24 2006-02-20 Федеральное государственное унитарное предприятие Государственный научный центр - Институт биофизики Федерального медико-биологического агентства (ГНЦ-ИБФ) Способ фотон-захватной терапии опухолей
US7874975B2 (en) * 2005-07-20 2011-01-25 Clear Vascular, Inc. Methods and compositions for treating luminal inflammatory disease
RU2313838C1 (ru) * 2006-12-29 2007-12-27 Институт ядерных исследований РАН ИЯИ РАН Способ получения радиоолова в состоянии без носителя и мишень для его осуществления (варианты)
US20090104234A1 (en) * 2007-10-23 2009-04-23 Allergan, Inc. Methods of treating chronic neurogenic inflammation using modified clostridial toxins
EP2545560B1 (de) * 2010-03-10 2014-01-22 The South African Nuclear Energy Corporation Limited Verfahren zur herstellung von radionukliden
KR102006599B1 (ko) 2011-12-21 2019-08-01 아이소테라퓨틱스 그룹 엘엘씨 방사성 조성물 및 그의 치료적 사용 방법
RU2533267C1 (ru) * 2013-10-07 2014-11-20 Государственное бюджетное образовательное учреждение высшего профессионального образования "Тихоокеанский государственный медицинский университет" Министерства здравоохранения Российской Федерации (ГБОУ ВПО ТГМУ Минздрава России) Способ фотон-захватной терапии опухолей
WO2016191413A1 (en) * 2015-05-25 2016-12-01 Iso Therapeutics Group, Llc Dotmp kit formulations for radioisotopes
US11369700B2 (en) 2015-05-25 2022-06-28 IGL Pharma Inc. DOTMP kit formulations for radioisotopes

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4533541A (en) 1983-08-25 1985-08-06 The United States Of America As Represented By The United States Department Of Energy Tin-117m-labeled stannic (Sn4+) chelates
CA2232411A1 (en) * 1995-09-18 1997-03-27 Mallinckrodt Medical, Inc. (radio) labelled biotin derivatives

Also Published As

Publication number Publication date
JP3122319B2 (ja) 2001-01-09
ES2314977T3 (es) 2009-03-16
CN1149836A (zh) 1997-05-14
AU2391495A (en) 1995-11-29
RU2160121C2 (ru) 2000-12-10
EP0758252A1 (de) 1997-02-19
JPH07309783A (ja) 1995-11-28
EP0758252B1 (de) 2008-09-03
AU708204B2 (en) 1999-07-29
JPH08208528A (ja) 1996-08-13
WO1995029706A1 (en) 1995-11-09
US5853695A (en) 1998-12-29
HU9603039D0 (en) 1997-01-28
HUT75311A (en) 1997-05-28
DK0758252T3 (da) 2009-01-05
CN1216644C (zh) 2005-08-31
US6517810B1 (en) 2003-02-11
HU221423B1 (en) 2002-09-28
CA2188133A1 (en) 1995-11-09
CA2188133C (en) 2000-08-08
PT758252E (pt) 2008-12-16
ZA953393B (en) 1996-02-09
DE69535828D1 (de) 2008-10-16

Similar Documents

Publication Publication Date Title
DE69535828D1 (de) Radiotherapeutische mittel enthaltend zin-117m
GEP20053473B (en) High Potency Dihydroergotamine Compositions
IL133585A0 (en) Soluble prodrugs of paclitaxel
EP1514105A4 (de) Verfahren zur modulation der tubulindeacetylase-aktivität
NO20101190L (no) Anvendelse av buprenorfin i fremstillingen av et medikament
IS1907B (is) Notkun klóbindiefnisins klíókínól við að framleiða lyfjablöndu til að meðhöndla Alzheimers-sjúkdóm
PL309693A1 (en) Combined osteoporosis inhibiting treatment
EP0902789A4 (de)
IL81573A (en) Pharmaceutical preparations for the treatment of psoriasis containing tamoxifen
BR9813318A (pt) Processo de tratamento de tumores e degeneração macular em paciente humano ou veterinário, composição farmacêutica para tratamento de tumores e degeneração macular em um paciente humano ou veterinário
DE69424777D1 (de) 3,4-diarylchromane zur behandlung von dermatitis
GB9103764D0 (en) Compositions
MY111623A (en) Neuroprotective compounds
ATE13488T1 (de) Gallium-chlorid, ein neues antikrebsmittel.
TW374085B (en) Novel piperidine derivatives, their preparation, pharmaceutical formulation and medical use
DE69314586D1 (de) Arzneimittelzusammensetzung enthaltend TCF-II
MX9702671A (es) Derivados metalocenicos de diariletileno, metodos de preparacion y composiciones farmaceuticas que contienen estos derivados.
YU25202A (sh) Supstituisani piroli kao antiproliferativna sredstva za lečenje kancera
UA34350A (uk) Спосіб комплексного лікування генералізованого пародонтиту
UA30251A (uk) Спосіб лікування гіпертонії сфінктера одді у хворих на хронічний безкам'яний холецистит при поєднанні з підвищенням тонусу симпатичної нервової системи
UA28644A (uk) Спосіб лікування первинної аменореї центрального генезу у дівчат-підлітків
UA36137A (uk) Спосіб лікування хворих на хронічне легеневе серце
NZ336321A (en) Use of benzothiophene (raloxifene) for treating breast cancer
IT1271292B (it) Composizioni farmaceutiche contenenti melatonina e inibitori dei recettori degli estrogeni
UA30699A (uk) Спосіб лікування генералізованого пародонтиту

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 0758252

Country of ref document: EP